GENE EXPRESSION FOR LYMPHANGIOGENIC FACTORS IN ORAL MUCOSAL SQUAMOUS CELL CARCINOMA
![]() |
Park, Young-Wook
(Department of Oral & Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University)
Kim, Seong-Gon (Department of Oral & Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University) Kim, So-Hee (Department of Pharmacology, College of Dentistry, Gangneung-Wonju National University) Kim, Han-Seok (Department of Oral & Maxillofacial Surgery, Gangneung Asan Hospital, University of Ulsan College of Medicine) Kim, Min-Keun (Department of Dentistry, The Armed Forces Gangneung Hospital) |
1 | Zeng Y, Opeskin K, Baldwin ME et al : Expression of vascular endothelial cell growth factor reseptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Clin Cancer Res 10 : 5137, 2004 DOI ScienceOn |
2 | Bilde A, von Buchwald C, Therkildsen MH et al : Need for intensive histopathologic analysis to determine lymph node metastases when using sentinel node biopsy in oral cancer. Laryngoscope 118(3) : 408, 2008 DOI ScienceOn |
3 | He Y, Rajantie I, Pajusola K et al : Vascular endothelial cell growth factor reseptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65 : 4739, 2005 DOI ScienceOn |
4 | McGeown JG, McHale.NG, Thornbury KD : The role of external compression and movement in lymph propulsion in the sheep hind limb. J Physiol 387 : 83, 1987 DOI PUBMED |
5 | Yokoyama Y, Chanrnock-Jones DS, Licence D et al : Vascular endothelial growth fator-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer 88 : 237, 2003 DOI ScienceOn |
6 | Schoppmann SF, Bayer G, Aumayr K et al : Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 240 : 306, 2004 DOI PUBMED ScienceOn |
7 | Shushanov S, Bronstein M, Adelaide J et al : VEGF-C and VEGFR3 expression in human thyroid pathologies. Int J Cancer 86 : 47, 2000 DOI ScienceOn |
8 | Ku SJ, Chang YI, Chae CH et al : Static tensional forces increase osteogenic gene expression in three-dimensional periodontal ligament cell culture. BMB reports 42(7) : 427, 2009 PUBMED |
9 | Sleeman JP : The lymph node as a bridgehead in the metastatic dissemination of tumours. Recent Results Cancer Res 157 : 55, 2000 PUBMED |
10 | Stacker SA, Williams RA Achen MG (2004) Lymphangiogenic growth factors as markers of tumor metastasis. APMIS 112 : 539, 2004 DOI ScienceOn |
11 | Saharinen P, Tammela T, Karkkainen MJ et al : Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation, Trends Immunol 25 : 387, 2004 DOI ScienceOn |
12 | Beierle EA, Dai W, Langham MR et al : VEGF receptors are differentially expressed by neuroblastoma cells in culture. J Pediatr Surg 38(3) : 514, 2003 DOI ScienceOn |
13 | Zeng Y, Opeskin K, Horvath LG et al : Lymphatic vessel density and lymph node metastasis in prostate cancer. Prostate 65 : 222, 2005 DOI ScienceOn |
14 | Oliver G, Harvey N : A stepwise model of the development of lymphatic vasculature. Ann NY Acad Sci 979 : 159, 2002 DOI ScienceOn |
15 | Renvi-Vamos F, Tovari J, Fillinger J et al : Lymphangiogenesis correlates with lymph node metastasis. prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clin Cancer Res 11 : 7344, 2005 DOI ScienceOn |
16 | Cupedo T, Mebius RE : Role of chemokines in the development of secondary and tertiary lymphoid tissues. Semin Immunil 15 : 243, 2003 DOI ScienceOn |
17 | Scavelli,C.,Weber E., Agliano.M. et al : Lymphatics at the crossroads of angiogenesis and lyimphangiogenesis. J Anat 204 : 433, 2004 DOI ScienceOn |
18 | Grandi C, Alloisio M, Moglia D et al : Prognostic significance of lymphatic spread in head and neck carcinomas: Therapeutic implications. Head Neck Surg 8 : 67, 1985 DOI ScienceOn |
19 | Neuchrist C, Erovic BM, Handisurya A et al : Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Head Neck 25(6) : 464, 2003 DOI ScienceOn |
20 | Shibuya M, Claesson-Welsh L : Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 312 : 549, 2006 DOI ScienceOn |
21 | Oliver G, Detmar M : The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev 16 : 773, 2002 DOI ScienceOn |
22 | Bock JM, Sinclair LL, Bedford NS et al : Modulation of cellular invasion by VEGF-C expression in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 134(4) : 355, 2008 DOI ScienceOn |
23 | Kitadai Y, Kodama M, Cho S et al : Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes. Int J Cancer 115 : 388, 2005 DOI ScienceOn |
24 | Wey JS, Stoeltzing O, Ellis LM : Vascular endothelial growth factor receptors: expression and function in solid tumors. Clin Adv Hematol Onco 2(1) : 37, 2004 |
25 | Cochran AJ, Wen DR, Morton DL : Management of the ragional lymph nodes in patients with cutaneous malignant melanoma. World J Surg 16 : 214, 1992 DOI ScienceOn |
26 | Neuchrist C, Erovic BM, Handisurya A et al : Vascular endothelial growth factor receptor 2 (VEGFR2) expression in squamous cell carcinoma of the head and neck. Laryngoscope 111 : 1834, 2001 DOI ScienceOn |
27 | Wigle JT Oliver G : Proxl function is required for the development of the murine lymphatic system. Cell 98 : 769, 1999 DOI ScienceOn |
28 | Achen MG, Jeltsch M, Kukk E et al : Vascular endothelial growth fator-D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flk4). Proc Natl Acad Sci USA 95 : 548, 1998 DOI ScienceOn |
29 | Witte D, Thomas A, Ali N et al : Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma. Anticancer Res 22(3) : 1463, 2002 PUBMED |
30 | Silverman S Jr : Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Amer Dent Assoc 132(Suppl) : 7S-11S, 2001 DOI |
![]() |